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ABSTRACT 
Objective: The aim of the present work was to synthesize and characterize a series of 6- substituted benzimidazole-2-carbamic acid derivatives and 
evaluate them for antimicrobial activity.  
Methods: A novel series of 6-substituted benzimidazole-2-carbamic acid derivatives (6a-f) were synthesized by reacting substituted benzyl 
chlorides (2a-c) with 4-hydroxy -2- nitro aniline (3) in the presence of anhydrous K2CO3 in acetone. The series of 4-benzyl oxy -2-nitro anilines (4a-
c) thus obtained were reduced with Raney nickel as catalyst. The 4-substituted-1, 2-phenylene diamines were then reacted with 1, 3- bis (alkoxy 
carbonyl)-S-methyl isothiourea (5a-b) to yield the final compounds (6a-f). The structures of synthesized compounds were established by 1
Results: All compounds showed moderate to good antibacterial and antifungal activity and were nearly effective as the standard antibacterial and 
antifungal drugs used for comparison. The exhibited good activity against gram negative bacterial strains like K. pneumoniae and P. aeruginosa as 
well as against fungal strain C. albicans. 
H NMR 
and mass spectroscopy. The synthesized compounds were screened for antibacterial and antifungal activity against five pathogenic bacterial strains 
and two pathogenic fungal strains. 
Conclusion: The  6-substituted benzimidazole-2-carbamates. compounds synthesized and evaluated for pharmacological activity are promising as 
antimicrobial agents and are amenable for further optimization. 
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INTRODUCTION 
Molecules containing benzimidazole ring system have been 
extensively researched and reviewed. Compounds containing 
benzimidazole moiety have been reported to possess varied 
pharmacological activities such as antiulcer, anti-hypertensive, 
antimicrobial, antihistaminic, and anti-psychotic [1-4]. A vast 
number of benzimidazole derivatives bearing the substituent either 
on the benzene ring or imidazole nucleus have been synthesized 
leading to novel, biologically active molecules. Noteworthy amongst 
these are the 2-substituted benzimidazoles possessing antifungal 
activity [5, 6]. Substitution at 2-position on benzimidazole nucleus 
enhances antifungal activity manifold. Some of these derivatives 
contain an alkyl carbamate function at 2-position with the alkyl 
group containing 1-7 carbon atoms. Some examples of molecules 
belonging to this category are carbendazim, benomyl, cypendazole 
and have been put in to commercial use for controlling plant fungal 
diseases and are of economic importance [7-9]. These fungicides 
interact with β-tubulin protein and inhibit spindle formation thus 
accounting for their anti-mitotic activity resulting in cell death [10]. 
The widespread use of these agents has resulted in development of 
resistant strains of fungi.  
Opportunistic fungal infections in humans are a cause of serious 
concern and none of the benzimidazoles presently available in the 
market are effective in humans. The 2-substituted benzimidazoles 
bearing a suitable substituent in the benzene ring have been 
reported in literature to possess significant antibacterial activity 
[11-14]. Benzimidazoles compete with purines due to their 
structural similarity, thus resulting in inhibition of synthesis of 
bacterial nucleic acids and proteins. The incidence of microbial 
infections has assumed alarming proportions worldwide because of 
the indiscriminate use of existing antimicrobial agents which 
resulted in drug resistance. Lack of newer antimicrobial agents 
which are efficacious has increased morbidity, mortality and health 
care costs. In order to overcome these challenges, there is a greater 
need to develop novel and effective molecules possessing 
antibacterial and antifungal activity. The present work is aimed 
towards developing novel benzimidazole-2-carbamic acid 
derivatives bearing suitable substituents at 5(6) position and with 
improved potential for treating bacterial and fungal infections. A 
critical analysis of the structures of known antibacterial agents with 
benzimidazole as the central moiety indicated the importance of 
substitution at 2 and 5(6) positions for retaining 
antibacterial/antifungal activity. Hence in the designing of novel 
molecules emphasis was on varying the nature of substituents at 2 
and 5(6) positions on benzimidazole ring. This led to designing 
novel 6-substituted benzyl oxy benzimidazole-2-carbamates with 
simultaneously changing the carbamate alkyl group to study its 
contribution to activity. The nature of substituents on the benzyl 
group was chosen carefully again based on the literature data 
available on existing derivatives. The newly designed molecules 
were then synthesized by efficient synthetic process with emphasis 
on reducing side products. The synthesized compounds were 
purified, characterized by 1H NMR and mass spectroscopy and 
evaluated for antibacterial and antifungal activity.  
MATERIALS AND METHODS 
All synthesized compounds were purified by a simple 
recrystallization process. The melting points were recorded in open 
capillary tube and are uncorrected. 1H NMR spectra were recorded 
on 500 MHz Bruker NMR spectrometer using CDCl3 or DMSO-D6 as 
solvent and tetra methyl silane was used as reference. Mass spectra 
were obtained using ESI LC-MS Schimadzu mass spectrometer. All 
reactions were monitored by thin layer chromatography using 
precoated silica gel GF254
The substituted benzimidazole-2-carbamates were synthesized by 
reacting substituted 1, 2-phenylene diamine with thiourea synthon 
generated in situ as shown in Table 1 [15-17]. 
 aluminium plates purchased from E. 
Merck. Other chemicals were procured from commercial sources 
and used without further purification. 
Experimental Procedure 
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Table 1: It shows thiourea synthon for introduction of carbamate group at 2-position in benzimidazole 
S. No. Synthon Structure Reference 















Appropriately substituted benzyl alcohols (1a-c) were used as 
starting materials. The benzyl alcohols were reacted with thionyl 
chloride in diethyl ether at 0° C and gradually stirred at room 
temperature for 2-24 hours to yield the corresponding substituted 
benzyl chlorides (2a-c). The reaction of the benzyl chlorides (2a-c) 
with 4-hydroxy -2- nitro aniline (3) in refluxing acetone in presence 
of anhydrous K2CO3
General procedure for synthesis of 4-benzyl oxy-2-nitro 
anilines (4a-c) 
 gave 4-benzyl oxy -2-nitro anilines (4a-c). The 
nitro groups in 4a-c were then reduced using hydrazine hydrate and 
Raney nickel as catalyst. The 4-substituted 1, 2-phenylene diamines 
were obtained as a solution in ethanol by filtering the reaction 
mixture. 1, 3-bis (alkoxy carbonyl)–S-methyl isothiourea derivatives 
(5a-b) were generated in situ using S-methyl isothiouronium sulfate 
and alkyl chloroformate in the presence of KOH/NaOH. Finally the 
reaction of 4-substituted 1, 2-phenylene diamines with compounds 
5a-b in the presence of refluxing glacial acetic acid gave 6-
substituted benzimidazole derivatives (6a-f) having an alkyl 
carbamate group at the 2-position (scheme 1). 
A mixture of 4-hydroxy -2- nitro aniline (3) (2.31 g, 0.015 mol), 
anhydrous potassium carbonate (3.5 g, 0.025 mol) and substituted 
benzyl chlorides (2a-c) (3.24 g, 0.015 mol) was stirred in 40 ml of 
dry acetone and heated at reflux for 24-48 hrs. The mixture was 
cooled and poured into ice. The separated solid was filtered, washed 
with water and dried. The solid were redissolved in acetone and 
0.1N NaOH was added till precipitation was complete, filtered and 
dried. This gave 4a-c as yellow to orange solids in sufficiently pure 
form. 4a-M. P. 130º (80.4%) Rf value 0.62, 4b- M. P. 88º (82.3%) Rf 
value 0.48, 4c- M. P. 85º (78.52%) Rf
General procedure for synthesis of 4-substituted-1, 2-
phenylene diamines 
 value 0.43.  
A stirred suspension of appropriate benzyl oxy derivative (4a-c) 
(0.44 g, 1.32 mmol) in 10 ml of ethanol was treated with Raney 
nickel slurry in water (3.0 g). Hydrazine hydrate (3.0 ml, 85 % 
solution in water) was added drop wise. The mixture was stirred for 
45-60 mins. The solution was filtered and the solvent was 
evaporated. The obtained oil was immediately cyclo-condensed 
without further purification. 
General procedure for synthesis of 6-substituted benzyl oxy 
benzimidazoles (6a-f) 
To a solution of S-methyl isothiouronium sulphate in water (0.8 g, 6.06 
mmol), the alkyl chloroformate (1.14 g, 12.12 mmol) was added all at 
once after cooling to 0ºC using ice-salt mixture. A solution of 25 % 
aqueous NaOH/KOH was added drop wise and pH was adjusted to 7-8. 
The pH and temperature of the reaction was maintained at 7-8 and 0-
5ºC respectively for about 1 hr 15 mins. The obtained 1,3-bis (alkoxy 
carbonyl)- S-methyl isothiourea (5a-b) formed in situ was treated with 
glacial acetic acid added drop wise over a period of 15 mins to adjust the 
pH to 3-4 followed by addition of 4-substituted 1, 2-phenylene diamine 
(1.8 g, 6.06 mmol) in one portion. The resulting mixture was warmed to 
100ºC and refluxed for a period of 2-3 hrs. Solid benzimidazole 
derivatives were isolated by filtration and washed well with water and 
air-dried. They were then purified by dissolving in chloroform-methanol 
(9:1). Evaporation of the solvent gave 6a-f in pure form. 
Anti microbial Evaluation 
The synthesized compounds (6a-f) were screened for antibacterial 
and antifungal activity by cup plate (well diffusion) method [18-20]. 
The strains of bacteria used were Staphylococcus aureus ATCC 9144, 
Bacillus subtilis ATCC 6633, Escherichia coli ATCC 25922, Klebsiella 
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The fungal strains used were Candida albicans ATCC 2091 and 
Aspergillus niger 16404 and obtained from Food and Drugs 
Administration, Govt. of Maharashtra, Mumbai. The microbial 
cultures were characterized using morphology and staining 
technique prior to use in the screening. The media used for 
antibacterial testing was nutrient agar. The media used for 
antifungal testing was Saboraud’s Chloramphenicol Agar. These 
were procured from HiMedia Pvt. Ltd. Mumbai. The stock culture 
was maintained on agar slants and stored at 4ºC. All the strains were 
sub cultured on the appropriate agar plate 24 h prior to 
antimicrobial evaluation of test compounds. The cultures were 
prepared by inoculating loopful of suspension from freshly prepared 
slants to nutrient broth (for bacteria) and Saboraud’s 
Chloramphenicol broth (for fungi) and incubated at 37ºC for 24 hrs.  
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A particular volume of enriched broth was diluted in sterile saline 
and the turbidity of resulting suspension of organism was matched 
with 0.5 McFarland standard to contain approximately 1.5 x 108
 
 
CFU/ml. Antibacterial activity was determined against a standard 
antibiotic such as Ceftriaxone disodium 0.25mg/ml and antifungal 
activity was determined using standard antifungal agent fluconazole 
0.25 mg/ml. Stock solutions of the test compounds and standards 
with concentrations 1mg/ml were made in DMSO.  
Appropriate dilutions of the test and standard stock solutions were 
also made in DMSO to yield a final concentration of 0.1 mg/ml for 
the test compounds and 0.25 mg/ml for the standards used. DMSO 
was used as control against all the organisms. The minimum 
inhibitory concentrations were also determined by agar plate 
method and it was taken to be as the lowest concentration that 
produces no visible turbidity after incubation. Molten sterile 
nutrient agar (20 ml) was poured in presterilized Petri plate and 
allowed to solidify.  
The bacterial/fungal suspension (0.1 ml) was spread uniformly 
using a glass spreader. Wells of standard diameters was made in the 
nutrient agar medium using a sterile cork borer of 8 mm. The test 
and standard compounds were introduced in to the wells using 
micropipette with sterile tips.  
The agar plates were incubated at 37ºC for 24 hours. The diameter 
of the zone of inhibition was measured in mm by subtracting the 
diameter of borer from each reading. The test was carried out in 
triplicates and the mean value of these readings was recorded. 
RESULTS AND DISCUSSION 
The physical constants and spectral characteristics of the key 
intermediate 4- benzyl oxy-2-nitro anilines (4a-c) are shown in 
Table 2. Mass spectra and 1H NMR confirmed structures of nitro 
anilines synthesized. Table 3 and Table 4 give the physical constants 
and the spectral characteristics of 6-substituted benzimidazole-2-
carbamates (6a-f). The final compounds corresponded with their 
m/z mass values in the mass spectrum and 1
Table 2: It shows the spectral data of 4- benzyl oxy-2-nitro anilines (4a-c). 
H NMR spectra obtained 
were also in accordance with the structures envisaged. The results 
of the antimicrobial activity are shown in Table 5. The compounds 
exhibited moderate to good activity against the bacterial strains S. 
aureus, K. pneumoniae and P. aeruginosa and fungal strains C. 
albicans and A. niger. They were found to be as effective as the 
standards Ceftriaxone and fluconazole respectively. The activity of 
the compounds was found to be poor against B. subtilis. Compounds 
6b, 6d and 6f showed good activity against E. coli whereas 
compounds 6a, 6c and 6e showed poor activity against this 
organism. The activity of all the compounds against fungal strain C. 
albicans was found to be slightly better than A. niger.  The overall 
antibacterial activities for the gram negative bacterial strains such as 
K. pneumoniae and P. aeruginosa were better than E. coli and gram 
positive bacteria. The compounds exhibited moderate activity 
against S. aureus in comparison to B. subtilis. The minimum 
inhibitory concentration for the compounds as shown in table 6 
ranged from 50-100 mcg/ml for S. aureus, K. pneumoniae and P. 
aeruginosa, for E. coli it ranged from 75- 125 mcg/ml, for B. subtilis 
the values were somewhat higher ranging from 100-150 mcg/ml 
whereas for C. albicans and A. niger it ranged from 25-50 mcg/ml. 
Compound 
No. 
1 Mass spectrum m/z values (% rel. 
intensity) 
HNMR (δ in ppm) 
4a δ 3.6-4.0 (m, 9H, -OCH3), δ 4.9-5.0 (s, 2H, -CH2), δ 5.9-6.0 (br. s, 2H,-NH2 333.2 (MH̄,100) ), δ 6.8-7.6 
(m, 5H, PhH).  
4b δ 3.90 (s, 6H, -OCH3), δ 5.20(s, 2H, -CH2
-NH
), δ 5.80 (br. s, 2H, 
2
302.8 
), δ 6.80-7.80 (m, 6H, PhH). (MH̄,100) 
4c δ 3.70-3.90 (s, 6H, -OCH3), δ 5.08(s, 2H,-CH2Ar), δ 6.02 (br. s, 2H,-NH2 302.7 (MH̄,100) ), δ 6.90-7.00 
(m, 6H, PhH). 
 
Table 3: It shows physical constants of substituted Benzimidazoles (6a-f). 
Compound 
No. 





6a C19H21N3O 387 6 205-207 42 
6b C20H23N3O 401 6 145-150 40 
6c C18H19N3O 357 5 198-202 35 
6d C19H21N3O 371 5 136-138 37 
6e C18H19N3O 357 5 193-196 42 
6f C19H21N3O 371 5 134-136 45 
* Percent yield calculated on basis of benzyl oxy derivative (4a-c) used as starting material for obtaining substituted benzimidazoles (6a-f). 
 
Table 4: It shows spectral data of substituted Benzimidazoles (6a-f). 
Compound 
No. 
1 Mass spectra HNMR (δ in ppm) 
m/z values (% rel. 
intensity) 
6a δ 3.4 (s,3H, -OCH3), δ 3.66,3.74 and 3.82 (s, 9H, -OCH3), δ 4.98(s,2H,-CH2 388.2 (MHAr), δ 6.78(s,2H,PhH), δ 7.02-




6b δ 1.25 (t,3H,-CH2CH3), δ 3.40,3.69 and 3.78 (s, 9H, -OCH3), δ 4.15(q,2H,-CH2CH3),δ 5.00(s,2H,-CH2 403.4 (MHAr), δ 




6c δ 3.72,3.77 and 3.82 (s, 9H, -OCH3), δ 5.04(s,2H,-CH2 358.0 (MHAr), δ 6.73-6.77(d,1H,5H), δ 7.05-7.07(s,3H,PhH), δ 




6d δ 1.43-1.48 (t,3H,-CH2CH3), δ 3.87 (s, 6H, -OCH3), δ 4.36-4.43(q,2H,-CH2CH3),δ 5.16(s,2H,-CH2 372.2 (MHAr), δ 




6e δ 3.69, 3.72 and 3.79 (s, 9H, -OCH3, δ 5.18(s,2H,-CH2 358.0 (MHAr), δ 6.77-7.10(m,4H,5H and PhH), δ 7.24(s,1H,4H), δ 




6f δ 1.27 (t,3H,-CH2CH3), δ 3.78 and 3.73 (s, 6H, -OCH3), δ 4.17 (q,2H,-CH2CH3),δ 5.27(s,2H,-CH2 372.2 (MHAr), δ 6.80-
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Table 5: It shows in vitro data for antimicrobial screening of Benzimidazoles (6a-f). 
Compd Zone of Inhibition (mm) 
S. aureus B. subtilis E. coli K. pneumoniae P. aeruginosa C. albicans A. niger 
6a 8±0.50 trace trace 11±0.35 9±0.20 13±0.30 10±0.12 
6b 9±0.20 trace 14±0.21 12±0.35 9±0.50 15±0.35 8±0.50 
6c 10±0.30 trace trace 13±0.50 10±0.35 11±0.50 9±0.20 
6d 11±0.32 trace 12±0.21 12±0.12 11±0.50 12±0.50 8±0.50 
6e 9±0.20 trace trace 12±0.12 9±0.20 13±0.21 10±0.35 
6f 10±0.32 trace 13±0.50 11±0.35 10±0.20 14±0.21 12±0.20 
CEFT 10±0.12 8±0.5 7±0.22 12±0.50 10±0.22 - - 
FLU - - - - - 12±0.20 11±0.20 
CEFT-Ceftriaxone, FLU-Fluconazole. Zone diameter values are expressed as mean ± s. d. 
 
Table 6: It shows MIC (Minimum Inhibitory Concentration) for antibacterial and antifungal activity of Benzimidazoles (6a-f). 
Micro-organisms Minimum Inhibitory Concentration (mcg/ml) 
6a 6b 6c 6d 6e 6f 
S. aureus ATCC 9144 50 100 50 75 50 100 
B. subtilis ATCC 6633 150 125  100 125 100 150 
E. coli ATCC 25922 125 75 100 75 100 75 
K. pneumoniae ATCC 29665 50 50 50 50 50 50 
P. aeruginosa ATCC 15442 75 50 50 50 50 50 
C. albicans ATCC 2091 35 25 25 25  25 35 




A novel series of  6-substituted Benzimidazole-2-carbamates.were 
synthesized and characterized by spectral analysis. They exhibited 
moderate to good antibacterial and antifungal activity. These results 
are promising indeed and the findings of this study imply that these 
compounds have potential for further development and 
optimization study. 
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